Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Titin PEVK region is a specialized, intrinsically disordered domain within the giant protein titin (also known as connectin), located in the I-band of the muscle sarcomere (UniProt Q8WZ42). It is characterized by a high density of proline (P), glutamate (E), valine (V), and lysine (K) residues, which allow it to act as an entropic spring that provides passive tension during muscle elongation (Linke & Hamdani, 2014). This region is a major determinant of myocardial diastolic stiffness and is highly regulated by post-translational modifications, particularly phosphorylation by kinases such as protein kinase G (PKG), protein kinase A (PKA), and protein kinase C (PKC) (Hamdani et al., 2013). In diseases like heart failure with preserved ejection fraction (HFpEF), the PEVK region is often hypophosphorylated, contributing to increased ventricular stiffness and diastolic dysfunction (Borbély et al., 2005). While direct-binding small molecules for the PEVK region are not yet in clinical use, it is a primary downstream target for heart failure therapies that enhance cGMP-PKG signaling, such as neprilysin inhibitors and soluble guanylate cyclase stimulators. Understanding the mechanical properties and regulatory pathways of the PEVK region is essential for developing precision treatments for cardiomyopathies and other muscle-related disorders.
Modulation of passive myocardial stiffness through the regulation of phosphorylation sites within the PEVK domain by cGMP/PKG and cAMP/PKA signaling pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Titin PEVK region (PEVK).